After a correction of more than 27% from the previous peak, it's showing a sign of rebound. Short term target at 51.43 after confirmation at 48.95.
It's good to know the advancement oft $VCYT in lung cancer detection and collaboration with $JNJ .
It's good to know the advancement oft $VCYT in lung cancer detection and collaboration with $JNJ .